ReviewFrontiers in endocrinology2022

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes.

Xintong Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.